Performance overview
Value at beginning of month: $131,204.33
Value at end of month: $135,877.90
Month over month change: +3.56%
Total IRR: 17.67%
Related indices, monthly change
NASDAQ: +2.28%
IVV (iShares Core S&P 500): +4.08%
IBB (iShares NASDAQ Biotechnology Index): +5.30%
MXI (iShares Global Materials): +1.33%
VEGI (iShares MSCI Global Agriculture Producers): +4.07%
ICLN (iShares Clean Energy): +11.26%
Individual performances
Both Codexis and Ziopharm had a great month. Codexis closed a week out at a valuation of over $1 billion for the first time in its history. Ziopharm rose thanks to a positive update to a Phase I clinical trial. On the opposite end, Amyris presented some pretty rough Q3 data. The stock dropped around 30% that day and has yet to recover.
Changes made to index
Added Twist Bioscience.
You can view the index here.
Allocation as of November 30, 2018
